易事特(300376.SZ)半年度淨利潤預增10%~30%
格隆匯7月6日丨易事特(300376.SZ)公吿,預計2021年上半年歸屬於上市公司股東的淨利潤約2.04億元~2.41億元,同比增長10%~30%。
報吿期內,公司持續深耕高端電源裝備、數據中心、5G供電、儲能、充電樁設備及光伏發電等新能源戰略性新興產業,深入參與到大行業、大項目的開拓、方案設計及落地執行,提升了公司產品和服務的利潤率。其中,高端電源裝備及數據中心業務、光伏發電業務穩步增長。本報吿期內實現的歸屬於上市公司股東淨利潤較上年同期亦同步增長。預計公司2021年上半年非經常性損益金額約為1600萬元,主要為政府補貼。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.